The arrival of Retatrutide ZPHC, at a concentration of 120mg, is sparking considerable excitement within the weight loss community. This novel dual GIP and GLP-1 agonist medication appears to offer significant improvements in fat loss compared to previous therapies. Initial clinical trials have d